Mr. Keisuke Harada

FRONTEO Aims to Develop the World's First Linguistic AI Medical Device

FRONTEO is developing a “conversational dementia diagnostic support AI program” that screens for cognitive dysfunction using AI and natural language. This program is the first linguistic AI program medical device in Japan, and clinical trials started in April 2021. Mr. Keisuke Harada, who has ten years of experience in pharmaceutical clinical development, will explain this AI program.